Novel nanosystems for the treatment of ocular inflammation: Current paradigms and future research directions

Ocular discomforts involve anterior/posterior-segment diseases, symptomatic distress and associated inflammations and severe retinal disorders

Lida Lalu

2017

Scholarcy highlights

  • Ocular discomforts involve anterior/posterior-segment diseases, symptomatic distress and associated inflammations and severe retinal disorders
  • Development of nanotechnology based nanomedicines and novel nanosystems are currently in progress. It is one of the central concept in designing more accessible formulations for deeper segments of the eyes. These nanosystems has largely enabled the availability of medicaments at required site in a required concentration without inversely affecting the eye tissues; and attaining the excessive considerations from the formulation scientists and pharmacologists worldwide
  • The entrapment of drugs, genes, and proteins inside these novel systems is the basis that works at the bio-molecular level bestows greater potential to eradicate disease causatives
  • The progress described may pave the way to new, highly effective and vital ocular nanosystems

Need more features? Save interactive summary cards to your Scholarcy Library.